Soluble Epoxide Hydrolase Inhibitor, T-Aucb, Improves Salivary Gland Function by Ameliorating Endothelial Injury.

Wen-wen Han,Xiao-rui Wang,Yu-feng He,Han-shu Zhang,Xin Cong,Ruo-Lan Xiang,Li-Ling Wu,Guang-Yan Yu,Li-mei Liu,Yan Zhang
DOI: https://doi.org/10.1016/j.lfs.2022.120942
IF: 6.78
2022-01-01
Life Sciences
Abstract:Aims: Inhibitor of soluble epoxide hydrolase (t-AUCB) has been used in the experimental therapy of hypertension. This study aimed to investigate whether the secretion of submandibular glands (SMGs) altered in renal hyper-tensive rats, and to explore whether t-AUCB could improve the salivary secretion.Main methods: 2-kidney 1-clip Sprague-Dawley rats were used as renal hypertensive animals. t-AUCB treatment was given for 1 week after 8 weeks modeling. Blood pressure, blood perfusion and the secretion of SMGs, and endothelium-dependent relaxation of external maxillary artery were measured to investigate the effects of t-AUCB on the vascular tone and the secretion of SMGs in renal hypertensive rats. SMGs were collected for his-tological evaluation and the internal arteries were dissected for primary endothelial cells culture.Key findings: The blood perfusion and flow rate of SMGs in the renal hypertensive rats were significantly lower than those in the controls. Endothelium-dependent relaxation of the external maxillary artery and AMPK/Akt/ eNOS signaling was impaired in hypertensive rats. The glandular morphology and the concentration of salivary ions did not change obviously. t-AUCB treatment ameliorated the secretion of SMGs, the blood perfusion, and the dysfunction of endothelium-dependent relaxation of the external maxillary artery by activating the AMPK/Akt/ eNOS pathway in hypertensive rats.Significance: t-AUCB increases the blood perfusion through ameliorating dysfunction of endothelium-dependent relaxation of SMGs arteries and thus improves the hyposecretion of SMGs in hypertensive rats.
What problem does this paper attempt to address?